RxDoctor Payments Data

Robert Lester, MD

Family Medicine · Calhoun, GANPI 1982643177

Payments from drug & device makers

$9,703in general payments, 2019–2025

Across 614 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Pfizer$1K
  • AbbVie$1K
  • Lilly USA, LLC$687
  • AstraZeneca$626
  • Amgen$622
  • plus $5K from 44 others

What the payments were for

  • Speaking & faculty fees$651%
  • Food & beverage$9,62599%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,703 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$132,363
Medicare patients
303
Services billed
2,620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide129$151,577
FarxigaDapagliflozin Propanediol176$142,637
OzempicSemaglutide109$141,233
JardianceEmpagliflozin129$136,505
EliquisApixaban134$114,786
Trelegy ElliptaFluticasone/Umeclidin/Vilanter92$66,099
XareltoRivaroxaban49$50,620
EntrestoSacubitril/Valsartan49$39,496
GemtesaVibegron29$21,735
Breo ElliptaFluticasone/Vilanterol23$17,830
TrulicityDulaglutide12$14,979
JanuviaSitagliptin Phosphate14$14,864
Repatha SyringeEvolocumab22$11,949
Stiolto RespimatTiotropium Br/Olodaterol Hcl18$9,188
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$7,282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$687$166,556141 claims
AstraZenecaFarxiga, Symbicort$626$149,793198 claims
Boehringer IngelheimJardiance, Stiolto Respimat, Synjardy Xr$388$148,856158 claims
Novo NordiskOzempic$1,108$141,233109 claims
PfizerEliquis, Premarin$1,073$119,112152 claims
GSKTrelegy Ellipta, Breo Ellipta$418$83,929115 claims
Johnson & JohnsonXarelto$69$50,62049 claims
NovartisEntresto$108$39,49649 claims
Sumitomo Pharma America, Inc.Gemtesa$160$21,73529 claims
MerckJanuvia$306$14,86414 claims
AbbVieSynthroid$1,015$2,46347 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Calhoun

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →